Genetic modulation of fetal hemoglobin in hydroxyurea-treated sickle cell anemia
- PMID: 28195442
- PMCID: PMC5389903
- DOI: 10.1002/ajh.24680
Genetic modulation of fetal hemoglobin in hydroxyurea-treated sickle cell anemia
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Cardoso GL, Diniz IG, Silva AN, et al. DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil. Blood Cells, Mol & Dis. 2014;53:176–179. - PubMed
-
- Sheehan VA, Luo Z, Flanagan JM, et al. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes. Am J Hematol. 2013;88:571–576. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical